AtriCure (ATRC) Reports Prelim. 3Q18 Revenues Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rebounds, but yield surge sets stage for weekly losses
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
- SpaceX shares fall as second lockup period ends
AtriCure (ATRC) Prices 2.5M Shares Common Offering at $30.75/Sh
October 5, 2018 5:42 AM EDTAtriCure, Inc. (NASDAQ: ATRC) today announced the pricing of its underwritten offering of 2.5 million shares of its common stock at a price to the public of $30.75 per share pursuant to its existing shelf registration statement. Net proceeds to AtriCure from the offering are expected to be... More
AtriCure (ATRC) Announces Proposed 2.5M Share Common Offering
October 3, 2018 4:02 PM EDTAtriCure, Inc. (NASDAQ: ATRC) today announced it has commenced an underwritten public offering of 2.5 million shares of its common stock pursuant to its existing shelf registration statement. In connection with this offering, AtriCure plans to grant the underwriters of the offering a 30-day option to... More
